Cell Cycling Models of Carcinogenesis: A Complex Systems Analysis
AI-generated Key Points
⚠The license of the paper does not allow us to build upon its content and the key points are generated using the paper metadata rather than the full article.
- The article proposes a new approach to analyzing the nonlinear dynamics involved in cell cycling network transformations during carcinogenesis.
- Carcinogenesis is complex and involves interconnected biomolecules across various compartments.
- Cell cyclins are proteins that link several critical pro-apoptotic and other cell cycling/division components.
- TP53, Thomsen-Friedenreich antigen (T antigen), Rb, mdm2, c-Myc, p21, p27, Bax, Bad and Bcl-2 all play major roles in neoplastic transformation of many tissues.
- The authors propose a novel theoretical analysis based on recently published studies of cyclin signaling with special emphasis placed on the roles of cyclins D1 and E.
- This analysis suggests potential clinical trials and rational therapies for cancer through reestablishment of cell cycling inhibition in metastatic cancer cells.
- The article provides valuable insights into the complex systems involved in carcinogenesis.
Authors: V. I. Prisecaru, I. C. Baianu
Abstract: A new approach to the modular, complex systems analysis of nonlinear dynamics in cell cycling network transformations involved in carcinogenesis is proposed. Carcinogenesis is a complex process that involves dynamically inter-connected biomolecules in the intercellular, membrane, cytosolic, nuclear and nucleolar compartments that form numerous inter-related pathways. One such family of pathways contains the cell cyclins. Cyclins are proteins that link several critical pro-apoptotic and other cell cycling/division components, including the tumor suppressor gene TP53 and its product, the Thomsen-Friedenreich antigen (T antigen), Rb, mdm2, c-Myc, p21, p27, Bax, Bad and Bcl-2, which all play major roles in neoplastic transformation of many tissues. This novel theoretical analysis based on recently published studies of cyclin signaling, with special emphasis placed on the roles of cyclins D1 and E, suggests novel clinical trials and rational therapies of cancer through reestablishment of cell cycling inhibition in metastatic cancer cells.
Ask questions about this paper to our AI assistant
You can also chat with multiple papers at once here.
⚠The license of the paper does not allow us to build upon its content and the AI assistant only knows about the paper metadata rather than the full article.
Assess the quality of the AI-generated content by voting
Score: 0
Why do we need votes?
Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.
The previous summary was created more than a year ago and can be re-run (if necessary) by clicking on the Run button below.
⚠The license of this specific paper does not allow us to build upon its content and the summarizing tools will be run using the paper metadata rather than the full article. However, it still does a good job, and you can also try our tools on papers with more open licenses.
Similar papers summarized with our AI tools
Navigate through even more similar papers through a
tree representationLook for similar papers (in beta version)
By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.
Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.